Form 4: Stoke Therapeutics Director Reports Stock Transaction
Insider Transaction (Form 4)
Seth Loring Harrison, a Director of Stoke Therapeutics, Inc., reported multiple transactions in common stock on July 16, 2026.
Summary
- Bona fide gift: disposed of 29,555 Stock Option (Right to Buy) on July 16, 2026 (Direct).
- Bona fide gift: acquired 29,555 Stock Option (Right to Buy) on July 16, 2026; holds 29,555 after (Indirect).
- Bona fide gift: disposed of 14,777 Stock Option (Right to Buy) on July 16, 2026 (Direct).
- Bona fide gift: acquired 14,777 Stock Option (Right to Buy) on July 16, 2026; holds 14,777 after (Indirect).
- Bona fide gift: disposed of 11,650 Stock Option (Right to Buy) on July 16, 2026 (Direct).
- Bona fide gift: acquired 11,650 Stock Option (Right to Buy) on July 16, 2026; holds 11,650 after (Indirect).
- Bona fide gift: disposed of 21,000 Stock Option (Right to Buy) on July 16, 2026 (Direct).
- Bona fide gift: acquired 21,000 Stock Option (Right to Buy) on July 16, 2026; holds 21,000 after (Indirect).
- Bona fide gift: disposed of 19,441 Stock Option (Right to Buy) on July 16, 2026 (Direct).
- Bona fide gift: acquired 19,441 Stock Option (Right to Buy) on July 16, 2026; holds 19,441 after (Indirect).
- Bona fide gift: disposed of 7,639 Stock Option (Right to Buy) on July 16, 2026 (Direct).
- Bona fide gift: acquired 7,639 Stock Option (Right to Buy) on July 16, 2026; holds 7,639 after (Indirect).
- Bona fide gift: disposed of 29,747 Stock Option (Right to Buy) on July 16, 2026 (Direct).
- Bona fide gift: acquired 29,747 Stock Option (Right to Buy) on July 16, 2026; holds 29,747 after (Indirect).
- Bona fide gift: disposed of 17,786 Stock Option (Right to Buy) on July 16, 2026 (Direct).
- Bona fide gift: acquired 17,786 Stock Option (Right to Buy) on July 16, 2026; holds 17,786 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Seth Loring Harrison — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-16 | Bona fide gift | Stock Option (Right to Buy) | 29,555 | — | — | 0 |
| 2026-07-16 | Bona fide gift | Stock Option (Right to Buy) | 29,555 | — | — | 29,555 |
| 2026-07-16 | Bona fide gift | Stock Option (Right to Buy) | 14,777 | — | — | 0 |
| 2026-07-16 | Bona fide gift | Stock Option (Right to Buy) | 14,777 | — | — | 14,777 |
| 2026-07-16 | Bona fide gift | Stock Option (Right to Buy) | 11,650 | — | — | 0 |
| 2026-07-16 | Bona fide gift | Stock Option (Right to Buy) | 11,650 | — | — | 11,650 |
| 2026-07-16 | Bona fide gift | Stock Option (Right to Buy) | 21,000 | — | — | 0 |
| 2026-07-16 | Bona fide gift | Stock Option (Right to Buy) | 21,000 | — | — | 21,000 |
| 2026-07-16 | Bona fide gift | Stock Option (Right to Buy) | 19,441 | — | — | 0 |
| 2026-07-16 | Bona fide gift | Stock Option (Right to Buy) | 19,441 | — | — | 19,441 |
| 2026-07-16 | Bona fide gift | Stock Option (Right to Buy) | 7,639 | — | — | 0 |
| 2026-07-16 | Bona fide gift | Stock Option (Right to Buy) | 7,639 | — | — | 7,639 |
| 2026-07-16 | Bona fide gift | Stock Option (Right to Buy) | 29,747 | — | — | 0 |
| 2026-07-16 | Bona fide gift | Stock Option (Right to Buy) | 29,747 | — | — | 29,747 |
| 2026-07-16 | Bona fide gift | Stock Option (Right to Buy) | 17,786 | — | — | 0 |
| 2026-07-16 | Bona fide gift | Stock Option (Right to Buy) | 17,786 | — | — | 17,786 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-16 | Bona fide gift (29,555 shares) |
| 2026-07-16 | Bona fide gift (29,555 shares) |
| 2026-07-16 | Bona fide gift (14,777 shares) |
| 2026-07-16 | Bona fide gift (14,777 shares) |
| 2026-07-16 | Bona fide gift (11,650 shares) |
| 2026-07-16 | Bona fide gift (11,650 shares) |
| 2026-07-16 | Bona fide gift (21,000 shares) |
| 2026-07-16 | Bona fide gift (21,000 shares) |
| 2026-07-16 | Bona fide gift (19,441 shares) |
| 2026-07-16 | Bona fide gift (19,441 shares) |
| 2026-07-16 | Bona fide gift (7,639 shares) |
| 2026-07-16 | Bona fide gift (7,639 shares) |
| 2026-07-16 | Bona fide gift (29,747 shares) |
| 2026-07-16 | Bona fide gift (29,747 shares) |
| 2026-07-16 | Bona fide gift (17,786 shares) |
| 2026-07-16 | Bona fide gift (17,786 shares) |
Keywords
insider transaction, Form 4, STOK, Stoke Therapeutics, Inc., neutral, Seth Loring Harrison
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.